Professor
University of Colorado School of Medicine Department of Otolarynoglogy
Aurora, CO, United States
Dr. Mona M. Abaza is a Professor and Vice Chair of Faculty Affairs and Diversity for the Department of
Otolaryngology at the University of Colorado, School of Medicine. A board certified and Laryngology fellowship
trained Otolaryngologist, she received her medical degree from The Women’s Medical College of Pennsylvania
(now Drexel University). She is the first surgical member of the University of Colorado School of Medicine’s Academy of Medical Educators and ran its Teaching Certificate Program. She held the position of Residency Program Director for Otolaryngology for over 18 years, stepping down in 2018 to take the Vice Chair position. She is the Past Chair of the Otolaryngology Program Director Organization (OPDO) and former founding member of the Administrative Board member for the Council of Faculty and Academic Societies (CFAS) of the American Association of Medical Colleges (AAMC), where she chaired the Faculty Resilience Working Group. She is a past member of the Accreditation Council of Graduate Medical Education (ACGME) Board of Directors sitting on several committees, including the Governance, Executive and Education committees. She also passionate about improving women’s leadership development in her specialty and academic medicine. She was a founding member of the governing council of the women’s section of her national academy, past-chair of the section and developed and ran a leadership development program. She is the founder and President of the Otolaryngology Women’s Leadership Society, developed to expand the leadership program and networking opportunities for women in her specialty. She is currently on the Advisory Panel for the Societies Consortium for Sexual Harassment in STEMM, on the student engagement Task Force.
Leadership Lessons: Strategies for Success
Monday, September 30, 2024
1:00 PM – 2:00 PM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.